Maddrey's Discriminant Function for Alcoholic Hepatitis

ورودی‌های بالینی بیمار

حداقل ۸ — حداکثر ۱۲۰ • واحد: seconds

حداقل ۸ — حداکثر ۲۰ • واحد: seconds

حداقل ۰.۱ — حداکثر ۵۰ • واحد: mg/dL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
maddrey score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Mild to Moderate0–31
  • Severe32–1000
Direct Clinical Answer

The Maddrey's Discriminant Function for Alcoholic Hepatitis calculates predicting prognosis and steroid benefit in alcoholic hepatitis. Key inputs include patient pt. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Predicts prognosis and steroid benefit in alcoholic hepatitis

Clinical Indication

The Maddrey's Discriminant Function for Alcoholic Hepatitis is indicated for bedside clinical practice to support Predicts prognosis and steroid benefit in alcoholic hepatitis. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Should be used in conjunction with contraindications assessment for steroids.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Often combined with Lille score to assess treatment response.

Formula & Variables:

Maddrey's DF = 4.6 × (Patient's PT - Control PT) + Total Bilirubin

Input Parameters

NameTypeRequiredDescription
patient_ptfloatYesPatient's prothrombin time (PT)(seconds)
control_ptfloatYesControl/reference prothrombin time (PT)(seconds)
total_bilirubinfloatYesTotal bilirubin level(mg/dL)

Score Interpretation & Guidance

RangeStageDescription
0–31Mild to ModerateGood prognosis, steroid therapy not indicated
32–1000SeverePoor prognosis, consider steroid therapy

Evidence-Based References (EBM)

  • Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978 Aug;75(2):193-9. PMID: 352788.PMID: 352788
  • Carithers RL Jr, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 1989 May 1;110(9):685-90. doi: 10.7326/0003-4819-110-9-685.DOI: 10.7326/0003-4819-110-9-685
  • Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007 Jun;45(6):1348-54. doi: 10.1002/hep.21607.DOI: 10.1002/hep.21607

Related calculators